Published in
Cancer Treatment and Research Communications, (13), p. 3-8
DOI: 10.1016/j.ctarc.2017.07.002
Links
Tools
A real-world study on implementation of bevacizumab in a cohort of HER2-negative metastatic breast cancer patients: A study of the Southeast Netherlands Breast Cancer Consortium
Journal article published in 2017 by
R. J. W. van Kampen,
D. J. A. Lobbezoo,
M. de Boer,
M. W. Dercksen,
A. C. Voogd,
F. van den Berkmortel,
T. J. Smilde,
A. J. van de Wouw,
F. P. J. Peters,
J. M. G. van Riel,
N. A. J. B. Peters,
P. G. M. Peer,
M. A. Joore 
,
V. C. G. Tjan-Heijnen
,
V. C. G. Tjan-Heijnen
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 